The current BIOL market cap is 413.42k. The company's latest EPS is USD -12.5615 and P/E is -0.02.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 12.01M | 14.05M | 10.47M | 14.29M | 10.92M |
Operating Income | -7.65M | -8.43M | -5.29M | -3.87M | -3.7M |
Net Income | -8.39M | -10.08M | -5.85M | -4.87M | -4.59M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 46.16M | 37.8M | 22.78M | 39.19M | 48.46M |
Operating Income | -20.89M | -15.62M | -18.54M | -16.43M | -25.34M |
Net Income | -21.52M | -17.86M | -34.21M | -16.7M | -28.85M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 42.87M | 38.19M | 41.94M | 39.63M | 38.75M |
Total Liabilities | 29.01M | 33.3M | 33.79M | 32.29M | 32.86M |
Total Equity | 13.86M | 4.89M | 8.16M | 6.62M | 332k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 38.52M | 31.85M | 41.03M | 55.28M | 38.19M |
Total Liabilities | 27.43M | 27.51M | 31M | 30.08M | 33.3M |
Total Equity | 11.09M | 377k | 10.03M | 25.21M | 4.89M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -21.18M | -26.76M | -5.66M | -9.22M | -11.81M |
Investing | -3.26M | -3.73M | -587k | -944k | -1.13M |
Financing | 4.64M | 4.6M | 8.52M | 12.79M | 16.55M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.15M | -12.75M | -12.8M | -16.71M | -26.76M |
Investing | -522k | -207k | -96k | -707k | -3.73M |
Financing | 11.24M | 10.72M | 24.35M | 29.95M | 4.6M |
Market Cap | 413.42k |
Price to Earnings Ratio | -0.02 |
Price to Sales Ratio | 0.01 |
Price to Cash Ratio | 0.1 |
Price to Book Ratio | 0.09 |
Dividend Yield | - |
Shares Outstanding | 2.3M |
Average Volume (1 week) | 34.45M |
Average Volume (1 Month) | 11.24M |
52 Week Change | -99.57% |
52 Week High | 47.10 |
52 Week Low | 0.1251 |
Spread (Intraday) | 0 (0.44%) |
Company Name | Biolase Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.biolase.com |
Industry | dental equipment & supplies (3843) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.